Connection

Igor Roninson to Cell Line, Tumor

This is a "connection" page, showing publications Igor Roninson has written about Cell Line, Tumor.
Connection Strength

0.805
  1. Identifying Cancers Impacted by CDK8/19. Cells. 2019 08 03; 8(8).
    View in: PubMed
    Score: 0.117
  2. CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases. Cancer Res. 2018 12 01; 78(23):6594-6606.
    View in: PubMed
    Score: 0.110
  3. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc Natl Acad Sci U S A. 2012 Aug 21; 109(34):13799-804.
    View in: PubMed
    Score: 0.072
  4. Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ? 2 renders tumor cells dependent on its paralogous gene COPZ1. Proc Natl Acad Sci U S A. 2011 Jul 26; 108(30):12449-54.
    View in: PubMed
    Score: 0.067
  5. Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing. Proc Natl Acad Sci U S A. 2010 Apr 20; 107(16):7377-82.
    View in: PubMed
    Score: 0.061
  6. p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle. 2007 Jun 15; 6(12):1468-71.
    View in: PubMed
    Score: 0.050
  7. Cell cycle arrest drastically extends the duration of gene silencing after transient expression of short hairpin RNA. Cell Cycle. 2006 Oct; 5(20):2390-5.
    View in: PubMed
    Score: 0.048
  8. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells. Cancer Res. 2006 Sep 01; 66(17):8749-61.
    View in: PubMed
    Score: 0.048
  9. Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in?vitro and in?vivo. Proc Natl Acad Sci U S A. 2022 08 09; 119(32):e2201073119.
    View in: PubMed
    Score: 0.036
  10. A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics. J Med Chem. 2022 02 24; 65(4):3420-3433.
    View in: PubMed
    Score: 0.035
  11. The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs. Cells. 2021 01 12; 10(1).
    View in: PubMed
    Score: 0.032
  12. Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer. Oncogene. 2018 08; 37(35):4792-4808.
    View in: PubMed
    Score: 0.027
  13. Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer. Oncotarget. 2017 Feb 21; 8(8):12558-12575.
    View in: PubMed
    Score: 0.025
  14. Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells. Oncotarget. 2015 May 30; 6(15):13088-104.
    View in: PubMed
    Score: 0.022
  15. Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21. J Biol Chem. 2012 Mar 23; 287(13):9845-9854.
    View in: PubMed
    Score: 0.017
  16. Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro. Br J Cancer. 2009 Dec 01; 101(11):1900-8.
    View in: PubMed
    Score: 0.015
  17. Proteomic analysis of factors released from p21-overexpressing tumour cells. Proteomics. 2006 Jul; 6(13):3739-53.
    View in: PubMed
    Score: 0.012
  18. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1. Cancer Res. 2005 Oct 01; 65(19):8927-35.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.